Pediatrics

Top Story

FDA approves Flucelvax Quadrivalent

May 24, 2016

The FDA recently approved Flucelvax Quadrivalent — the first seasonal influenza vaccine to be cell-derived and to protect against the four major strains of influenza A and B — for patients aged 4 years and older, according to its manufacturer.

“Flucelvax Quadrivalent will provide health care providers and their patients with an important option to further broaden their influenza coverage,” Gordon Naylor, president of Seqirus, said in a press release. “We are pleased to offer Flucelvax Quadrivalent … to our valued customers during the 2016-2017 flu season.”

In the Journals

Trial quality, bias may diminish value of methylphenidate for ADHD

May 24, 2016
A recent clinical review in JAMA reported that evidence supporting the use of methylphenidate among adolescents for treatment of attention-deficit/hyperactivity disorder…
In the Journals

Ten percent of pregnant women received flu vaccine from 2005-2014

May 23, 2016
Findings published in Pediatrics showed that only 10% of pregnant women surveyed over 9 years had received the influenza vaccine. In addition, newborns were found to…
In the Journals

Media reports of NICU outbreaks linked to increased antibiotic use

May 23, 2016
Extensive media coverage of nosocomial infection outbreaks at three neonatal ICUs in Germany may have prompted overuse of third-line antibiotics, according to recent…
Meeting News Coverage

Health care transition readiness lags in pediatric EoE, EGE

May 22, 2016
SAN DIEGO — More than 75% of pediatric patients with eosinophilic esophagitis and eosinophilic gastroenteritis, along with their parents, reported no knowledge of…
More News Headlines »
Original Article

Sight-Threatening Retinopathy of Prematurity: Changing Trends in Treatment

Journal of Pediatric Ophthalmology and Strabismus, March/April 2016, Volume 53 Issue 2
To study the incidence and treatment of severe retinopathy of prematurity (ROP) in infants younger than 30 weeks'…
More »
CME Video

Case Challenges in Pediatric Fatty Liver: What to Look For and When to Refer

This activity is supported by an educational grant from Synageva BioPharma Corp.

Non-alcoholic fatty liver disease (NAFLD) is characterized by excess fat deposition in the liver due to causes other…
More »
Featured
PAS 2016

PAS 2016

Video
Meeting News Coverage

VIDEO: Flublok demonstrates superior efficacy over IIV

April 21, 2016
More »
morganatic-roan
morganatic-roan